Thursday, June 4, 2020

Bias, Corruption & Accountability

Royal College of Psychiatrists Accused of Misleading Claims

From The Herald: A group of mental health experts and patients have submitted a formal letter of complaint accusing the Royal College of Psychiatrists of...

“More on the Clinical Trial Disaster in France”

Just last week one person was declared brain dead and five more were hospitalized after taking a psychiatric drug in a clinical trial. Writing for Science, Martin Enserink provides more information about the drug as new details emerge.

New Study Explores Approaches to Discontinuing Antidepressants

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

JAMA Review Questions Use of Ritalin for ‘ADHD’

In December, MIA  reported on a systematic Cochrane review on the research for the safety and effectiveness of Ritalin (methylphenidate) that found substantial bias...

Researcher Critically Examines Movements for Global Mental Health

China Mills raises concerns that global mental health movements obscure social determinants of health and naturalize Western mental health concepts.

Trump Chooses Gottlieb to run FDA; Big Pharma Relieved

From Reuters: President Trump has selected Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the FDA. Article...

Ohio Attorney General Sues Prescription Opioid Manufacturers

Ohio Attorney General Mike DeWine has filed a lawsuit against five leading prescription opioid manufacturers and their related companies in Ross County Court of Common...

Patient Advocacy Groups Accept Drug Industry Funds

From The New York Times: A new study has found that more than 80 percent of the nation's patient advocacy groups accept funding from drug...

Less Than Half of Clinical Trials Comply with Legislation to Accurately Report Results

A new study finds that sponsors of clinical trials in the EU continue to fail at reporting their results as required by recent legislation.

Trump Wants to Blow up the FDA

From STAT: President Trump plans to decrease regulations on the Food and Drug Administration. Medical experts and healthcare professionals have expressed concerns that this could expose...

Drug Treatment of ADHD – Tenuous Scientific Basis

From Tidsskriftet: Over the past three decades, there has been a dramatic increase in the diagnosis and pharmacological treatment of ADHD. Recent systematic reviews reveal...

“Justina’s Law” seeks to curb experimentation on foster children

A bipartisan group of House lawmakers have introduced a bill called "Justina's Law" to limit federal funding for medical research involving foster children, according...

“Many Clinical Trials’ Findings Never Get Published. Here’s Why That’s Bad”

STAT’s watchdogs, Ivan Oransky and Adam Marcus, explain why unpublished studies for drug makers and researchers “put young patients at risk, particularly if those...

New Study Investigates Negative Side Effects of Therapy

Researchers find that nearly half of cognitive behavioral therapy (CBT) patients experience treatment side effects.

Study Challenges Assumption that Schizophrenia Impairs Cognitive Ability

Secondary factors may impair performance on cognitive tasks, making it difficult for individuals diagnosed with schizophrenia to perform to the best of their ability.

Does Active Placebo Response Explain Antidepressant Results?

A new study investigated whether participants guessing if they have an antidepressant or placebo affects response rates.

How Do Antidepressants Really ‘Work’?

A recent review, published in Neuroscience & Biobehavioral Reviews, challenges the dominant assumptions about the neurochemical and therapeutic effects of Selective Serotonin Reuptake Inhibitors...

You Might be in a Medical Experiment and not Even Know it

From Aeon: Medical experiments are increasingly being conducted without the informed consent of participants. Article →­

“Drug and Device Makers Paid $6.5 Billion to Docs and Teaching Hospitals Last Year”

From Ed Silverman with Pharmalot: “Drug and device makers paid nearly $6.5 billion in payments to doctors and teaching hospitals last year, according to...

Study Investigates Physicians’ Beliefs About Placebo and Nocebo Effects of Antidepressants

Surveyed doctors overestimate pharmacological effects of antidepressants and underestimate placebo effects.

NEJM Editorial Doubles Down on Resistance to Data Sharing

The New England Journal of Medicine came under fire earlier this year when editors wrote that new efforts for transparency and open data would...

Largest Meta-Analysis of Antidepressants Finds Doubled Risk of Suicide in Youth

The largest-ever meta-analysis of antidepressant trials appeared yesterday in the British Medical Journal. Researchers from the Cochrane Collaboration reviewed 70 trials (involving 18,526 subjects), to find that - counter to the initially-reported findings - antidepressants doubled the risk of suicide and aggression in subjects under 18. This risk had been misrepresented in the original study reports, the authors say, and suggest that the risks to adults may be similarly under-reported.

“Diagnostic Dissent”: Experiences of Individuals Who Disagreed With Their Diagnosis

Researchers investigate the first-person experiences of people who disagreed with their psychiatric diagnosis of psychosis.

Big Pharma Might Be Intentionally Confusing You

From Benzinga: The FDA has suggested that drug commercials may intentionally list potential side effects in such a rapid-fire, overwhelming way that the warning messages...

“Early Behavior Therapy Found to Aid Children With A.D.H.D.”

“Children with attention-deficit problems improve faster when the first treatment they receive is behavioral therapy — like instruction in basic social skills — than...

Follow Us